Medicom Conference Report EULAR 2023最新文献

筛选
英文 中文
Obesity in PsA is increasingly affecting male patients PsA中的肥胖越来越多地影响到男性患者
Medicom Conference Report EULAR 2023 Pub Date : 2023-07-31 DOI: 10.55788/672f4fe9
{"title":"Obesity in PsA is increasingly affecting male patients","authors":"","doi":"10.55788/672f4fe9","DOIUrl":"https://doi.org/10.55788/672f4fe9","url":null,"abstract":"","PeriodicalId":375429,"journal":{"name":"Medicom Conference Report EULAR 2023","volume":"51 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115117354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PsA patients: highest risk of developing NAFLD PsA患者:发生NAFLD的风险最高
Medicom Conference Report EULAR 2023 Pub Date : 2023-07-31 DOI: 10.55788/282e8c7b
{"title":"PsA patients: highest risk of developing NAFLD","authors":"","doi":"10.55788/282e8c7b","DOIUrl":"https://doi.org/10.55788/282e8c7b","url":null,"abstract":"","PeriodicalId":375429,"journal":{"name":"Medicom Conference Report EULAR 2023","volume":"358 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115946031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methotrexate lowers pain in inflammatory hand OA 甲氨蝶呤减轻炎性手关节炎的疼痛
Medicom Conference Report EULAR 2023 Pub Date : 2023-07-31 DOI: 10.55788/4808088e
{"title":"Methotrexate lowers pain in inflammatory hand OA","authors":"","doi":"10.55788/4808088e","DOIUrl":"https://doi.org/10.55788/4808088e","url":null,"abstract":"","PeriodicalId":375429,"journal":{"name":"Medicom Conference Report EULAR 2023","volume":"51 19","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"120817594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bimekizumab: high rates of sustained response in PsA 比美珠单抗:PsA的高持续应答率
Medicom Conference Report EULAR 2023 Pub Date : 2023-07-31 DOI: 10.55788/3a8f3dfb
{"title":"Bimekizumab: high rates of sustained response in PsA","authors":"","doi":"10.55788/3a8f3dfb","DOIUrl":"https://doi.org/10.55788/3a8f3dfb","url":null,"abstract":"","PeriodicalId":375429,"journal":{"name":"Medicom Conference Report EULAR 2023","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132296125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Poly-refractory RA: not common, but still present 聚难熔类风湿性关节炎:不常见,但仍然存在
Medicom Conference Report EULAR 2023 Pub Date : 2023-07-31 DOI: 10.55788/5c841567
{"title":"Poly-refractory RA: not common, but still present","authors":"","doi":"10.55788/5c841567","DOIUrl":"https://doi.org/10.55788/5c841567","url":null,"abstract":"","PeriodicalId":375429,"journal":{"name":"Medicom Conference Report EULAR 2023","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123081363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In vitro and in vivo studies confirm the role of regulatory volume decrease 体外和体内研究证实了调节体积减少的作用
Medicom Conference Report EULAR 2023 Pub Date : 2023-07-31 DOI: 10.55788/63e63afa
{"title":"In vitro and in vivo studies confirm the role of regulatory volume decrease","authors":"","doi":"10.55788/63e63afa","DOIUrl":"https://doi.org/10.55788/63e63afa","url":null,"abstract":"","PeriodicalId":375429,"journal":{"name":"Medicom Conference Report EULAR 2023","volume":"60 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127008583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disease activity-guided dose reduction may be a long-term option for stable RA 疾病活动引导的剂量减少可能是稳定类风湿性关节炎的长期选择
Medicom Conference Report EULAR 2023 Pub Date : 2023-07-31 DOI: 10.55788/8a5811cd
{"title":"Disease activity-guided dose reduction may be a long-term option for stable RA","authors":"","doi":"10.55788/8a5811cd","DOIUrl":"https://doi.org/10.55788/8a5811cd","url":null,"abstract":"","PeriodicalId":375429,"journal":{"name":"Medicom Conference Report EULAR 2023","volume":"90 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124756412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AxSpA: Adalimumab biosimilar equally effective as IL-17 inhibitor in hindering radiographic progression AxSpA:阿达木单抗生物类似药在阻碍放射学进展方面与IL-17抑制剂同样有效
Medicom Conference Report EULAR 2023 Pub Date : 2023-07-31 DOI: 10.55788/56d9ce70
{"title":"AxSpA: Adalimumab biosimilar equally effective as IL-17 inhibitor in hindering radiographic progression","authors":"","doi":"10.55788/56d9ce70","DOIUrl":"https://doi.org/10.55788/56d9ce70","url":null,"abstract":"","PeriodicalId":375429,"journal":{"name":"Medicom Conference Report EULAR 2023","volume":"45 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126812490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapy with biological DMARDs shows no correlation with fracture risk in RA 生物dmard治疗与RA骨折风险无相关性
Medicom Conference Report EULAR 2023 Pub Date : 2023-07-31 DOI: 10.55788/c6dcfee1
{"title":"Therapy with biological DMARDs shows no correlation with fracture risk in RA","authors":"","doi":"10.55788/c6dcfee1","DOIUrl":"https://doi.org/10.55788/c6dcfee1","url":null,"abstract":"","PeriodicalId":375429,"journal":{"name":"Medicom Conference Report EULAR 2023","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129935935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lorecivivint shows long-term benefits for severe knee OA lorecivive显示对严重膝关节炎的长期益处
Medicom Conference Report EULAR 2023 Pub Date : 2023-07-31 DOI: 10.55788/c6d0c272
{"title":"Lorecivivint shows long-term benefits for severe knee OA","authors":"","doi":"10.55788/c6d0c272","DOIUrl":"https://doi.org/10.55788/c6d0c272","url":null,"abstract":"","PeriodicalId":375429,"journal":{"name":"Medicom Conference Report EULAR 2023","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121018178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书